| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 18 | +72.22% | -3.23% | +0.53% | -3.76% | -5.91% | — |
| 14d | 18 | +72.22% | +0.60% | +1.13% | -0.54% | -4.51% | — |
| 30d | 18 | +61.11% | +3.15% | +2.14% | +1.00% | -7.34% | — |
| 60d | 18 | +44.44% | +9.32% | +5.17% | +4.15% | +1.88% | — |
| 90d | 18 | +66.67% | +3.16% | +5.51% | -2.35% | -12.29% | — |
| 180d | 18 | +61.11% | -11.10% | +13.61% | -24.71% | -21.16% | — |
| 1y | 18 | +83.33% | -38.29% | +24.68% | -62.97% | -70.74% | — |
| 2y | 18(1 pending) | +100.00% | -66.63% | +52.10% | -118.73% | -131.49% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 114,746 | $10.47 | $1.20M | 942,485 | Jun 22, 2026 | Jun 23, 2026 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 1,922 | $10.02 | $19.3K | 1,057,231 | Jun 1, 2026 | Jun 2, 2026 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 750,000 | — | — | 750,000 | Mar 25, 2026 | Mar 27, 2026 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 267,500 | — | — | 267,500 | Mar 6, 2025 | Mar 10, 2025 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE Chief Executive Officer | 1,270 | — | — | 148,730 | Jul 10, 2024 | Jul 12, 2024 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE Chief Executive Officer | 11,653 | — | — | 565,417 | Jul 10, 2024 | Jul 12, 2024 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 11,653 | $14.42 | $168.0K | 1,070,806 | Jul 10, 2024 | Jul 12, 2024 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 12,923 | $22.49 | $290.6K | 1,059,153 | Jul 10, 2024 | Jul 12, 2024 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 1,270 | $15.78 | $20.0K | 1,072,076 | Jul 10, 2024 | Jul 12, 2024 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 12,930 | $23.10 | $298.7K | 1,059,153 | Jun 24, 2024 | Jun 26, 2024 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 12,930 | $14.42 | $186.5K | 1,072,083 | Jun 24, 2024 | Jun 26, 2024 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE Chief Executive Officer | 12,930 | — | — | 577,070 | Jun 24, 2024 | Jun 26, 2024 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 92,001 | $27.13 | $2.50M | 1,059,153 | Feb 8, 2024 | Feb 12, 2024 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE Chief Executive Officer | 5,696 | $18.41 | $104.9K | 1,151,154 | Jan 23, 2024 | Jan 25, 2024 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 28,104 | $19.56 | $549.8K | 1,156,983 | Jan 5, 2024 | Jan 8, 2024 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 133 | $20.11 | $2.7K | 1,156,850 | Jan 5, 2024 | Jan 8, 2024 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 40,732 | $20.31 | $827.2K | 1,185,087 | Jan 4, 2024 | Jan 8, 2024 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 4,702 | $18.13 | $85.2K | 1,225,819 | Dec 18, 2023 | Jan 8, 2024 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 28,632 | $17.27 | $494.4K | 1,230,521 | Dec 15, 2023 | Jan 8, 2024 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 590,000 | — | — | 590,000 | Dec 11, 2023 | Dec 13, 2023 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALEGRANT Gift | 600,000 | — | — | 1,259,153 | May 2, 2023 | May 4, 2023 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | PURCHASEGRANT Gift | 600,000 | — | — | 600,000 | May 2, 2023 | May 4, 2023 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE Chief Executive Officer | 16,449 | $20.22 | $332.7K | 1,859,153 | Feb 22, 2023 | Feb 23, 2023 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE Chief Executive Officer | 17,090 | $20.93 | $357.7K | 1,876,509 | Feb 21, 2023 | Feb 23, 2023 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE Chief Executive Officer | 907 | $21.49 | $19.5K | 1,875,602 | Feb 21, 2023 | Feb 23, 2023 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 222,000 | — | — | 222,000 | Feb 10, 2023 | Feb 14, 2023 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE Chief Executive Officer | 8,625 | $20.19 | $174.1K | 1,893,599 | Jan 20, 2023 | Jan 23, 2023 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE Chief Executive Officer | 10,899 | $20.03 | $218.3K | 1,902,224 | Jan 19, 2023 | Jan 23, 2023 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE Chief Executive Officer | 26,349 | $23.39 | $616.2K | 1,913,123 | Dec 16, 2022 | Dec 19, 2022 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE Chief Executive Officer | 27,595 | $22.66 | $625.4K | 1,939,472 | Dec 16, 2022 | Dec 19, 2022 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE Chief Executive Officer | 31,433 | $23.56 | $740.6K | 1,968,567 | Dec 15, 2022 | Dec 19, 2022 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE Chief Executive Officer | 1,500 | $24.13 | $36.2K | 1,967,067 | Dec 15, 2022 | Dec 19, 2022 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 150,000 | — | — | 150,000 | Feb 1, 2022 | Feb 3, 2022 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 150,000 | — | — | 150,000 | Mar 8, 2021 | Mar 10, 2021 ↗ | View → |